Background: Two-dimensional synthetic MRI of the breast has limited spatial coverage. Three-dimensional (3D) synthetic MRI could provide volumetric quantitative parameters that may reflect the immunohistochemical (IHC) status in invasive ductal carcinoma (IDC) of the breast. Purpose: To evaluate the feasibility of 3D synthetic MRI using an interleaved Look–Locker acquisition sequence with a T2 preparation pulse (QALAS) for discriminating the IHC status, including hormone receptor (HR), human epidermal growth factor receptor 2 (HER 2), and Ki-67 expression in IDC. Study Type: Prospective observational study. Population: A total of 33 females with IDC of the breast (mean, 52.3 years). Field Strength/Sequence: A 3-T, 3D-QALAS gradient-echo and fat-suppressed T1-weighted 3D fast spoiled gradient-echo sequences. Assessment: Two radiologists semiautomatically delineated 3D regions of interest (ROIs) of the whole tumors on the dynamic MRI that was registered to the synthetic T1-weighted images acquired from 3D-QALAS. The mean T1 and T2 were measured for each IDC. Statistical Tests: Intraclass correlation coefficient for assessing interobserver agreement. Mann–Whitney U test to determine the relationship between the mean T1 or T2 and the IHC status. Multivariate logistic regression analysis followed by receiver operating characteristics (ROC) analysis for discriminating IHC status. A P value <0.05 was considered statistically significant. Results: The interobserver agreement was good to excellent. There was a significant difference in the mean T1 between HR-positive and HR-negative lesions, while the mean T2 value differed between HR-positive and HR-negative lesions, between the triple-negative and HR-positive or HER2-positive lesions, and between the Ki-67 level > 14% and ≤ 14%. Multivariate analysis showed that the mean T2 was higher in HR-negative IDC than in HR-positive IDC. ROC analysis revealed that the mean T2 was predictive for discriminating HR status, triple-negative status, and Ki-67 level. Data Conclusion: 3D synthetic MRI using QALAS may be useful for discriminating IHC status in IDC of the breast. Evidence Level: 1. Technical Efficacy: Stage 2.
CITATION STYLE
Amano, M., Fujita, S., Takei, N., Sano, K., Wada, A., Sato, K., … Aoki, S. (2023). Feasibility of Quantitative MRI Using 3D-QALAS for Discriminating Immunohistochemical Status in Invasive Ductal Carcinoma of the Breast. Journal of Magnetic Resonance Imaging, 58(6), 1752–1759. https://doi.org/10.1002/jmri.28683
Mendeley helps you to discover research relevant for your work.